FDA moves ahead with safety study of abortion pill mifepristone
The FDA is moving ahead with a safety study of the abortion pill mifepristone, a senior FDA official confirmed to CBS News, a step that could create a path for the Trump administration to restrict access to the medication.
Related News
RFK Jr. wants to overhaul the food system, but some of the health secretary’s initiatives are drawing resistance over fears they could drive up prices
Behind the scenes, some food companies and Trump administration officials are pushing to consider costs associated with…
The Wall Street Journal
• 46 minutes ago
Journalist in Iran's Evin Prison pleads for medical help for U.S. captives
CBS News has obtained a voice memo recorded by Iranian American journalist Reza Valizadeh, who has been detained in Evi…
Homan says N.J. ICE facility may not be "5-star resort" but is "well run"
In a CBS News interview, White House border czar Tom Homan defended conditions at the Delaney Hall ICE detention center…
More Senate races are up for grabs and there’s drama everywhere. Read more in today’s WSJ Politics newsletter:
Plus, the political rivalry between Kamala Harris and Gavin Newsom heads toward a 2028 showdown, and GOP senators stop …
The Wall Street Journal
• 1 hour ago
Republicans face ticking midterm clock as Iran fallout keeps pressure on gas prices
GOP strategists say Trump must resolve the Iran conflict soon as gas prices surge 35% and households face $750 in added…
GOP senators passed a $70 billion immigration-enforcement bill but stopped short of killing President Trump’s “anti-weaponization” fund
Some lawmakers had pressed for officially killing the president’s $1.8 billion “anti-weaponization” fund through legisl…
The Wall Street Journal
• 2 hours ago